Arcus Biosciences Inc Capital Reinvestment Ratio

Latest as of September 2024: 0.04x

Arcus Biosciences Inc capital reinvestment ratio. Arcus Biosciences Inc (RCUS) has a Capital Reinvestment Ratio of 0.04x as of September 2024, meaning it reinvests 0% of its operating cash flow ($26.00 Million) in capital expenditures ($1.00 Million). Check Arcus Biosciences Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.04x
Capex / Operating Cash Flow

Operating Cash Flow

$26.00 Million
USD

Capital Expenditures

$1.00 Million
USD

Data as of

Sep 2024
Most recent filing

Capital Reinvestment Ratio of Arcus Biosciences Inc (2020–2022)

Capital reinvestment ratio of Arcus Biosciences Inc from 2020 to 2022. This chart tracks Arcus Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore net asset growth rate of Arcus Biosciences Inc to track the company's year-over-year net asset growth rate.

Arcus Biosciences Inc Capital Reinvestment Ratio by Year (2020–2022)

Arcus Biosciences Inc capital reinvestment ratio by year from 2020 to 2022. For the full cash flow conversion analysis, see cash flow conversion of Arcus Biosciences Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2022 0.01x $438.00 Million $6.00 Million ▼ -50.2%
2020 0.03x $111.17 Million $3.06 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow